Patents by Inventor Keiichi Sakakibara

Keiichi Sakakibara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Peptides and peptidomimetics in combination uses and treatments for cancer patient subpopulations
    Patent number: 9221872
    Abstract: This invention provides compounds including peptides and peptidomimetics that can be used to treat cell proliferative disorders, such as those associated with benign and malignant tumor cells. While the invention is not limited to any particular mechanism, the compounds of the invention appear to function at least in part by inhibiting G2 cell cycle checkpoint. Thus, invention compounds can be used to inhibit cell growth alone or be used in combination with a nucleic acid damaging treatment to inhibit cell growth.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: December 29, 2015
    Assignee: CANBAS CO., LTD.
    Inventors: Takumi Kawabe, Naoki Mine, Naoya Saito, Keiichi Sakakibara, Takuji Sato
  • PEPTIDES AND PEPTIDOMIMETICS IN COMBINATION USES AND TREATMENTS FOR CANCER PATIENT SUBPOPULATIONS
    Publication number: 20150056301
    Abstract: This invention provides compounds including peptides and peptidomimetics that can be used to treat cell proliferative disorders, such as those associated with benign and malignant tumor cells. While the invention is not limited to any particular mechanism, the compounds of the invention appear to function at least in part by inhibiting G2 cell cycle checkpoint. Thus, invention compounds can be used to inhibit cell growth alone or be used in combination with a nucleic acid damaging treatment to inhibit cell growth.
    Type: Application
    Filed: June 24, 2014
    Publication date: February 26, 2015
    Inventors: Takumi Kawabe, Naoki Mine, Naoya Saito, Keiichi Sakakibara, Takuji Sato